@article {HOEHR2017200, title = {Medical Isotope Production at TRIUMF {\textendash} from Imaging to Treatment}, journal = {Physics Procedia}, volume = {90}, year = {2017}, note = {Conference on the Application of Accelerators in Research and Industry, CAARI 2016, 30 October {\textendash} 4 November 2016, Ft. Worth, TX, USA}, pages = {200 - 208}, abstract = {TRIUMF has a long history of medical isotope production. For more than 40 years, the Life Sciences Division at TRIUMF has produced isotopes for Positron Emission Tomography (PET) for the local hospitals. Recently, the division has taken on the challenge to expand the facility{\textquoteright}s isotope repertoire to isotopes for imaging to treatment. At the smallest cyclotron at TRIUMF with energy of 13 MeV, radiometals are being produced in a liquid target which is typically used for PET isotope production. This effort makes radiometals available for early stage research and preclinical trials. At beam energy of 24 MeV, we produce 99mTc from 100Mo with a cyclotron, the most common isotope for Single-Photon-Emission-Computed-Tomography (SPECT) and the most common isotope for nuclear imaging. The use of a cyclotron bypasses the common production route via a nuclear reactor as well as enriched uranium. And finally, at our 500 MeV cyclotron we have demonstrated the production of α emitters useful for targeted alpha therapy. Herein, these efforts are summarized.}, keywords = {alpha therapy isotopes, PET isotopes, SPECT isotopes, TC-99M}, issn = {1875-3892}, doi = {https://doi.org/10.1016/j.phpro.2017.09.059}, url = {http://www.sciencedirect.com/science/article/pii/S1875389217302183}, author = {C. Hoehr and F. B{\'e}nard and K. Buckley and J. Crawford and A. Gottberg and V. Hanemaayer and P. Kunz and K. Ladouceur and V. Radchenko and C. Ramogida and A. Robertson and T. Ruth and N. Zacchia and S. Zeisler and P. Schaffer} } @article {2370, title = {Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)(3)](+) core (M = Re, Tc)}, journal = {Dalton Transactions}, number = {42}, year = {2009}, note = {ISI Document Delivery No.: 508YBTimes Cited: 2Cited Reference Count: 32Bowen, Meryn L. Lim, Nathaniel C. Ewart, Charles B. Misri, Ripen Ferreira, Cara L. Haefeli, Urs Adam, Michael J. Orvig, Chris}, pages = {9216-9227}, type = {Article}, abstract = {The design rationale, synthesis and radiolabeling evaluation of four glucosamine conjugated ligands for the [Tc-99m(CO)(3)](+) core is described. The capability to bind the tricarbonyl core is initially demonstrated using the cold surrogate [Re(CO)(3)](+). The four compounds are competent chelates in binding [Tc-99m(CO)(3)](+) as labeling studies show, with yields ranging from 79 to 96\% and the resulting complexes showing stability in the presence of competing chelates for 24 h at 37 degrees C. The rhenium complexes were tested for hexokinase-catalysed phosphorylation, and the technetium complexes were tested for GLUT-1 mediated cell uptake - they showed a small amount of uptake but it was not glucose dependent, suggesting that it was not via the GLUT-1 transporters.}, keywords = {BIOMOLECULES, EXPRESSION, GLUT-1, HEXOKINASE, IN-VITRO, METAL-COMPLEXES, TC-99M, technetium, TRANSPORTERS, TRICARBONYL COMPLEXES}, isbn = {1477-9226}, url = {://000270973800020}, author = {Bowen, M. L. and Lim, N. C. and Ewart, C. B. and Misri, R. and Ferreira, C. L. and Hafeli, U. and Adam,Michael J. and Orvig, Chris} } @article {2370, title = {Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)(3)](+) core (M = Re, Tc)}, journal = {Dalton Transactions}, number = {42}, year = {2009}, note = {ISI Document Delivery No.: 508YBTimes Cited: 2Cited Reference Count: 32Bowen, Meryn L. Lim, Nathaniel C. Ewart, Charles B. Misri, Ripen Ferreira, Cara L. Haefeli, Urs Adam, Michael J. Orvig, Chris}, pages = {9216-9227}, type = {Article}, abstract = {The design rationale, synthesis and radiolabeling evaluation of four glucosamine conjugated ligands for the [Tc-99m(CO)(3)](+) core is described. The capability to bind the tricarbonyl core is initially demonstrated using the cold surrogate [Re(CO)(3)](+). The four compounds are competent chelates in binding [Tc-99m(CO)(3)](+) as labeling studies show, with yields ranging from 79 to 96\% and the resulting complexes showing stability in the presence of competing chelates for 24 h at 37 degrees C. The rhenium complexes were tested for hexokinase-catalysed phosphorylation, and the technetium complexes were tested for GLUT-1 mediated cell uptake - they showed a small amount of uptake but it was not glucose dependent, suggesting that it was not via the GLUT-1 transporters.}, keywords = {BIOMOLECULES, EXPRESSION, GLUT-1, HEXOKINASE, IN-VITRO, METAL-COMPLEXES, TC-99M, technetium, TRANSPORTERS, TRICARBONYL COMPLEXES}, isbn = {1477-9226}, url = {://000270973800020}, author = {Bowen, M. L. and Lim, N. C. and Ewart, C. B. and Misri, R. and Ferreira, C. L. and Hafeli, U. and Adam,Michael J. and Orvig, Chris} } @article {2369, title = {Long-chain rhenium and technetium glucosamine conjugates}, journal = {Dalton Transactions}, number = {42}, year = {2009}, note = {ISI Document Delivery No.: 508YBTimes Cited: 0Cited Reference Count: 44Bowen, Meryn L. Chen, Zhen-Feng Roos, Adrienne M. Misri, Ripen Haefeli, Urs Adam, Michael J. Orvig, Chris}, pages = {9228-9236}, type = {Article}, abstract = {A series of five glucosamine-conjugated organometallic complexes of the tricarbonyl cores of technetium-99m and rhenium were made. Glucosamine was derivatized at the C-2 nitrogen with long chain alkyl spacers linked to either pyridyl-tert-nitrogen-phenol tridentate chelates or cyclopentadienyl ligating groups. The metal complexes of the tridentate ligands were formed by refluxing with [Re(CO)(3)(H2O)(3)]Br, or with a base and [Tc-99m(CO)(3)(H2O)(3)](+). These ligands were found to be competent chelates in binding the [Tc-99m(CO)(3)](+) core as radiolabeling yields ranged from 87 to 93\% and the resulting complexes are stable to cysteine and histidine challenges for 24 h. The cyclopentadienyl analogues were formed using a double ligand transfer reaction for the rhenium complexes and a single ligand transfer for the technetium-99m complexes. All five rhenium complexes were tested as substrates of hexokinase; two of these complexes were tested as hexokinase inhibitors and they were found to be competent inhibitors, suggesting that they may be able to interact with hexokinase. MTT cytotoxicity studies were performed and the complexes tested were found to be non-toxic to the concentrations tested (100 mu M or 1 mM). GLUT-1 mediated cell uptake studies were performed on all five technetium-99m complexes, and their cell entry was found to parallel their lipophilicities, suggesting that cellular uptake is by passive diffusion and is not mediated by GLUT-1.}, keywords = {99M-TECHNETIUM, BIOMOLECULES, BREAST-CANCER, DERIVATIVES, HEXOKINASE, IN-VITRO, METAL-COMPLEXES, RE, TC-99M, TRANSPORT}, isbn = {1477-9226}, url = {://000270973800021}, author = {Bowen, M. L. and Chen, Z. F. and Roos, A. M. and Misri, R. and Hafeli, U. and Adam,Michael J. and Orvig, Chris} } @article {2369, title = {Long-chain rhenium and technetium glucosamine conjugates}, journal = {Dalton Transactions}, number = {42}, year = {2009}, note = {ISI Document Delivery No.: 508YBTimes Cited: 0Cited Reference Count: 44Bowen, Meryn L. Chen, Zhen-Feng Roos, Adrienne M. Misri, Ripen Haefeli, Urs Adam, Michael J. Orvig, Chris}, pages = {9228-9236}, type = {Article}, abstract = {A series of five glucosamine-conjugated organometallic complexes of the tricarbonyl cores of technetium-99m and rhenium were made. Glucosamine was derivatized at the C-2 nitrogen with long chain alkyl spacers linked to either pyridyl-tert-nitrogen-phenol tridentate chelates or cyclopentadienyl ligating groups. The metal complexes of the tridentate ligands were formed by refluxing with [Re(CO)(3)(H2O)(3)]Br, or with a base and [Tc-99m(CO)(3)(H2O)(3)](+). These ligands were found to be competent chelates in binding the [Tc-99m(CO)(3)](+) core as radiolabeling yields ranged from 87 to 93\% and the resulting complexes are stable to cysteine and histidine challenges for 24 h. The cyclopentadienyl analogues were formed using a double ligand transfer reaction for the rhenium complexes and a single ligand transfer for the technetium-99m complexes. All five rhenium complexes were tested as substrates of hexokinase; two of these complexes were tested as hexokinase inhibitors and they were found to be competent inhibitors, suggesting that they may be able to interact with hexokinase. MTT cytotoxicity studies were performed and the complexes tested were found to be non-toxic to the concentrations tested (100 mu M or 1 mM). GLUT-1 mediated cell uptake studies were performed on all five technetium-99m complexes, and their cell entry was found to parallel their lipophilicities, suggesting that cellular uptake is by passive diffusion and is not mediated by GLUT-1.}, keywords = {99M-TECHNETIUM, BIOMOLECULES, BREAST-CANCER, DERIVATIVES, HEXOKINASE, IN-VITRO, METAL-COMPLEXES, RE, TC-99M, TRANSPORT}, isbn = {1477-9226}, url = {://000270973800021}, author = {Bowen, M. L. and Chen, Z. F. and Roos, A. M. and Misri, R. and Hafeli, U. and Adam,Michael J. and Orvig, Chris} } @article {1392, title = {Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores}, journal = {Inorganic Chemistry}, volume = {45}, number = {17}, year = {2006}, note = {ISI Document Delivery No.: 073DPTimes Cited: 13Cited Reference Count: 43Ferreira, Cara L. Ewart, Charles B. Bayly, Simon R. Patrick, Brian O. Steele, Jennifer Adam, Michael J. Orvig, Chris}, month = {Aug}, pages = {6979-6987}, type = {Article}, abstract = {To obtain a Tc-99m glucose conjugate for imaging, double-ligand transfer (DLT) and related reactions were examined for the preparation of CpM(CO)(3) (Cp = cyclopentadienyl; M = Re, Tc) complexes with pendant carbohydrates at Cp. Tricarbonyl {N-(1,3,4,6-tetra-O-acetyl-2-amino-2-deoxy-beta-D-glucopyranose) cyclopentadienyl carboxamide} rhenium(I) (1a) and tricarbonyl {N-(2-amino-2-deoxy-beta-D-glucopyranose) cyclopentadienyl carboxamide} rhenium(I) (2a) were prepared. The compounds were fully characterized by mass spectrometry, elemental analysis, IR, and NMR spectroscopy. Full assignment of the NMR spectra verified the pendant nature of the glucosamine moieties in the solution state and that 2a exists as both anomers. The solid-state structure of 2a was determined by X-ray crystallography, again confirming the pendant nature of the glucosamine, but differing from the solution state in that the, anomer crystallized preferentially (93\%). Compound 2a was determined to be a high-affinity competitive inhibitor (K-i = 330 +/- 70 mu M) of the glucose metabolism enzyme hexokinase, demonstrating that it retains certain biological activity. The Tc-99m analogues 1b and 2b were prepared in moderate radiochemical yields by means of the single-ligand transfer (SLT) route, which is more pertinent to radiopharmaceutical synthesis.}, keywords = {BIOMOLECULES, COORDINATION, CYCLOPENTADIENYL-TRICARBONYL COMPLEXES, DERIVATIVES, FUNCTIONALIZATION, IN-VITRO, METAL-COMPLEXES, RE-186(I), RECEPTOR, TC-99M}, isbn = {0020-1669}, url = {://000239723300060}, author = {Ferreira, C. L. and Ewart, C. B. and Bayly, S. R. and Patrick, B. O. and Steele, J. and Adam,Michael J. and Orvig, Chris} } @article {1392, title = {Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores}, journal = {Inorganic Chemistry}, volume = {45}, number = {17}, year = {2006}, note = {ISI Document Delivery No.: 073DPTimes Cited: 13Cited Reference Count: 43Ferreira, Cara L. Ewart, Charles B. Bayly, Simon R. Patrick, Brian O. Steele, Jennifer Adam, Michael J. Orvig, Chris}, month = {Aug}, pages = {6979-6987}, type = {Article}, abstract = {To obtain a Tc-99m glucose conjugate for imaging, double-ligand transfer (DLT) and related reactions were examined for the preparation of CpM(CO)(3) (Cp = cyclopentadienyl; M = Re, Tc) complexes with pendant carbohydrates at Cp. Tricarbonyl {N-(1,3,4,6-tetra-O-acetyl-2-amino-2-deoxy-beta-D-glucopyranose) cyclopentadienyl carboxamide} rhenium(I) (1a) and tricarbonyl {N-(2-amino-2-deoxy-beta-D-glucopyranose) cyclopentadienyl carboxamide} rhenium(I) (2a) were prepared. The compounds were fully characterized by mass spectrometry, elemental analysis, IR, and NMR spectroscopy. Full assignment of the NMR spectra verified the pendant nature of the glucosamine moieties in the solution state and that 2a exists as both anomers. The solid-state structure of 2a was determined by X-ray crystallography, again confirming the pendant nature of the glucosamine, but differing from the solution state in that the, anomer crystallized preferentially (93\%). Compound 2a was determined to be a high-affinity competitive inhibitor (K-i = 330 +/- 70 mu M) of the glucose metabolism enzyme hexokinase, demonstrating that it retains certain biological activity. The Tc-99m analogues 1b and 2b were prepared in moderate radiochemical yields by means of the single-ligand transfer (SLT) route, which is more pertinent to radiopharmaceutical synthesis.}, keywords = {BIOMOLECULES, COORDINATION, CYCLOPENTADIENYL-TRICARBONYL COMPLEXES, DERIVATIVES, FUNCTIONALIZATION, IN-VITRO, METAL-COMPLEXES, RE-186(I), RECEPTOR, TC-99M}, isbn = {0020-1669}, url = {://000239723300060}, author = {Ferreira, C. L. and Ewart, C. B. and Bayly, S. R. and Patrick, B. O. and Steele, J. and Adam,Michael J. and Orvig, Chris} } @article {1125, title = {Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III)}, journal = {Bioconjugate Chemistry}, volume = {16}, number = {6}, year = {2005}, note = {ISI Document Delivery No.: 985QSTimes Cited: 17Cited Reference Count: 38}, month = {Nov-Dec}, pages = {1597-1609}, type = {Article}, abstract = {Gallium and indium complexes with pendant carbohydrates have been prepared and examined for their potential as radiopharmaceuticals. Carbohydrate-bearing 3-hydroxy-4-pyridinone ligand precursors and their tris(ligand)gallium(III) and -indium(III) complexes were synthesized and characterized by mass spectrometry, elemental analysis, and H-1 and C-13 NMR spectroscopy, and in the case of one intermediate, by X-ray crystallography. With three equivalents of ligand, neutral complexes formed with the bidentate hydroxypyridinone moiety complexing the gallium(III) and indium(III) metal centers.}, keywords = {aluminum, ANALOGS, CITRATE, GLUCOSE, INVIVO, SYSTEM, TC-99M}, isbn = {1043-1802}, url = {://000233393800036}, author = {Green, D. E. and Ferreira, C. L. and Stick, R. V. and Patrick, B. O. and Adam,Michael J. and Orvig, Chris} } @article {1125, title = {Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III)}, journal = {Bioconjugate Chemistry}, volume = {16}, number = {6}, year = {2005}, note = {ISI Document Delivery No.: 985QSTimes Cited: 17Cited Reference Count: 38}, month = {Nov-Dec}, pages = {1597-1609}, type = {Article}, abstract = {Gallium and indium complexes with pendant carbohydrates have been prepared and examined for their potential as radiopharmaceuticals. Carbohydrate-bearing 3-hydroxy-4-pyridinone ligand precursors and their tris(ligand)gallium(III) and -indium(III) complexes were synthesized and characterized by mass spectrometry, elemental analysis, and H-1 and C-13 NMR spectroscopy, and in the case of one intermediate, by X-ray crystallography. With three equivalents of ligand, neutral complexes formed with the bidentate hydroxypyridinone moiety complexing the gallium(III) and indium(III) metal centers.}, keywords = {aluminum, ANALOGS, CITRATE, GLUCOSE, INVIVO, SYSTEM, TC-99M}, isbn = {1043-1802}, url = {://000233393800036}, author = {Green, D. E. and Ferreira, C. L. and Stick, R. V. and Patrick, B. O. and Adam,Michael J. and Orvig, Chris} } @article {1266, title = {Novel carbohydrate-appended metal complexes for potential use in molecular imaging}, journal = {Chemistry-a European Journal}, volume = {11}, number = {1}, year = {2005}, note = {ISI Document Delivery No.: 887BZTimes Cited: 27Cited Reference Count: 60}, month = {Dec}, pages = {195-203}, type = {Article}, abstract = {Seven discrete sugar-pendant diamines were complexed to the {M(CO)(3)}(+) (Tc-99m/Re) core: 1,3-diamino-2-propyl beta-D-glucopyranoside (L-1), 1,3-diamino-2-propyl beta-D-xylopyranoside (L-2), 1,3-diamino-2-propyl alpha-D-mannopyranoside (L-3), 1,3-diamino-2-propyl alpha-D-galactopyranoside (L-4), 1,3diamino-2-propyl beta-D-galactopyranoside (L-5), 1,3-diamino-2-propyl beta-(alpha-D-glucopyranosyl-(1,4)-D-glucopyrano- side) (L-6), and bis(aminomethyl)bis[(beta-D-glucopyranosyloxy)methyl]methane (L-7). The Re complexes [Re((LL7)-L-1)(Br)(CO)(3)] were characterized by H-1 and C-13 1D/2D NMR spectroscopy which confirmed the pendant nature of the carbohydrate moieties in solution. Additional characterization was provided by IR spectroscopy, elemental analysis, and mass spectrometry. Two analogues, [Re(L-2)(CO)(3)Br] and [Re(L-3)(CO)(3)Br], were characterized in the solid state by X-ray crystallography and represent the first reported structures of Re organometallic carbohydrate compounds. Conductivity measurements in H2O established that the complexes exist as [Re(L-1-L-7)- (H2O)(CO)(3)]Br in aqueous conditions. Radiolabelling of V-L 7 with [Tc-99m(H2O)(3)(CO)(3)](+) afforded in high yield compounds of identical character to the Re analogues. The radiolabelled compounds were determined to exhibit high in vitro stability towards ligand exchange in the presence of an excess of either cysteine or histidine over a 24 h period.}, keywords = {AMINO-SUGARS, ANTITUMOR-ACTIVITY, carbohydrates, CRYSTAL-STRUCTURES, D-GLUCOSE, HIGH-AFFINITY, IN-VITRO, molecular imaging, PALLADIUM(II) COMPLEXES, RADIOPHARMACEUTICALS, rhenium, STRUCTURAL-CHARACTERIZATION, SUGAR-PENDANT, TC-99M, technetium}, isbn = {0947-6539}, url = {://000226278700018}, author = {Storr, T. and Obata, M. and Fisher, C. L. and Bayly, S. R. and Green, D. E. and Brudzinska, I. and Mikata, Y. and Patrick, B. O. and Adam,Michael J. and Yano, S. and Orvig, Chris} } @article {1266, title = {Novel carbohydrate-appended metal complexes for potential use in molecular imaging}, journal = {Chemistry-a European Journal}, volume = {11}, number = {1}, year = {2005}, note = {ISI Document Delivery No.: 887BZTimes Cited: 27Cited Reference Count: 60}, month = {Dec}, pages = {195-203}, type = {Article}, abstract = {Seven discrete sugar-pendant diamines were complexed to the {M(CO)(3)}(+) (Tc-99m/Re) core: 1,3-diamino-2-propyl beta-D-glucopyranoside (L-1), 1,3-diamino-2-propyl beta-D-xylopyranoside (L-2), 1,3-diamino-2-propyl alpha-D-mannopyranoside (L-3), 1,3-diamino-2-propyl alpha-D-galactopyranoside (L-4), 1,3diamino-2-propyl beta-D-galactopyranoside (L-5), 1,3-diamino-2-propyl beta-(alpha-D-glucopyranosyl-(1,4)-D-glucopyrano- side) (L-6), and bis(aminomethyl)bis[(beta-D-glucopyranosyloxy)methyl]methane (L-7). The Re complexes [Re((LL7)-L-1)(Br)(CO)(3)] were characterized by H-1 and C-13 1D/2D NMR spectroscopy which confirmed the pendant nature of the carbohydrate moieties in solution. Additional characterization was provided by IR spectroscopy, elemental analysis, and mass spectrometry. Two analogues, [Re(L-2)(CO)(3)Br] and [Re(L-3)(CO)(3)Br], were characterized in the solid state by X-ray crystallography and represent the first reported structures of Re organometallic carbohydrate compounds. Conductivity measurements in H2O established that the complexes exist as [Re(L-1-L-7)- (H2O)(CO)(3)]Br in aqueous conditions. Radiolabelling of V-L 7 with [Tc-99m(H2O)(3)(CO)(3)](+) afforded in high yield compounds of identical character to the Re analogues. The radiolabelled compounds were determined to exhibit high in vitro stability towards ligand exchange in the presence of an excess of either cysteine or histidine over a 24 h period.}, keywords = {AMINO-SUGARS, ANTITUMOR-ACTIVITY, carbohydrates, CRYSTAL-STRUCTURES, D-GLUCOSE, HIGH-AFFINITY, IN-VITRO, molecular imaging, PALLADIUM(II) COMPLEXES, RADIOPHARMACEUTICALS, rhenium, STRUCTURAL-CHARACTERIZATION, SUGAR-PENDANT, TC-99M, technetium}, isbn = {0947-6539}, url = {://000226278700018}, author = {Storr, T. and Obata, M. and Fisher, C. L. and Bayly, S. R. and Green, D. E. and Brudzinska, I. and Mikata, Y. and Patrick, B. O. and Adam,Michael J. and Yano, S. and Orvig, Chris} } @article {5115, title = {Complexes of phosphine-phenolate ligands with the [Re=O](3+) and [Re(HNNC5H4N)(NNC5H4N)](2+) cores}, journal = {Journal of the Chemical Society-Dalton Transactions}, number = {20}, year = {2001}, note = {ISI Document Delivery No.: 487VFTimes Cited: 5Cited Reference Count: 62}, pages = {3015-3024}, type = {Article}, abstract = {{Complexes incorporating the [Re=O](3+) core have been synthesised with ligands containing the new methyl substituted phosphine-phenolate PO and PO2 donor sets, (2-hydroxy-5-methylphenyl) diphenylphosphine (H(MePO)) and bis(2-hydroxy-5-methylphenyl) phenylphosphine (H-2(Me2PO2)). The analogous tert-butyl ligands, (5-tert-butyl-2-hydroxyphenyl)diphenylphosphine (H(t-BuPO)) and bis(5-tert-butyl-2-hydroxyphenyl) phenylphosphine (H-2 (t-Bu2PO2)), were also prepared. Reaction of either mer-[ReOCl3 (PPh3)(2)] or [NH4][ReO4] in CH3OH with H(MePO) led to formation of [ReOCl(MePO)(2)] (1) in good yield. Reaction of [NH4][ReO4] with H-2 (Me2PO2) in CH3OH afforded [ReO(Me2PO2)(H(Me2PO2))] (2), also in good yield. X-Ray crystallographic analyses of 1 and 2 demonstrated that both complexes are neutral and octahedral, and contain the oxo moiety. Two complexes have been structurally characterised from the reaction of (o-hydroxyphenyl) diphenylphosphine (HPO) with [Re(Hhypy)(hypyH)Cl-3]: [Re(Hhypy)(hypy)(PO)(HPO)]Cl (3) and [ReCl(Hypy)(hypy)(PO)] (4) (hypy = NNC5H4N}, keywords = {CHELATE COMPLEXES, COORDINATION-COMPOUNDS, CRYSTAL-STRUCTURE, IIB/IIIA-RECEPTOR ANTAGONIST, MOLECULAR-STRUCTURES, rhenium, STRUCTURE, TC-99M, TECHNETIUM RADIOPHARMACEUTICALS, WATER-SOLUBLE PHOSPHINES, X-RAY}, isbn = {1472-7773}, url = {://000171899200011}, author = {Kovacs, M. S. and Hein, P. and Sattarzadeh, S. and Patrick, B. O. and Emge, T. J. and Orvig, Chris} } @article {5231, title = {[ReO(N2O2)X] complexes: "4+1"?}, journal = {Inorganic Chemistry}, volume = {40}, number = {18}, year = {2001}, note = {ISI Document Delivery No.: 466JNTimes Cited: 3Cited Reference Count: 36}, month = {Aug}, pages = {4623-4626}, type = {Article}, abstract = {{[ReO(ppme)X] (where ppme(2-) is 2,5-diazo-N,N {\textquoteright} -dimethylhexyl-1,6-bis(phenylphosphinate)}, keywords = {CHEMISTRY, OXO-COMPLEXES, PEPTIDES, RADIOPHARMACEUTICALS, RHENIUM(V), SCHIFF-BASE LIGANDS, STABILITY, TC-99M, TECHNETIUM COMPLEXES, X-ray structures}, isbn = {0020-1669}, url = {://000170642600019}, author = {Xu, L. and Lowe, M. P. and Rettig, S. J. and Orvig, Chris} } @article {3815, title = {Bis(ligand) rhenium(V) and technetium(V) complexes of two naturally occurring binding moieties (oxazoline and thiazoline)}, journal = {Inorganic Chemistry}, volume = {35}, number = {2}, year = {1996}, note = {ISI Document Delivery No.: TR240Times Cited: 39Cited Reference Count: 19}, month = {Jan}, pages = {368-372}, type = {Article}, abstract = {{Attempts to prepare tris(ligand) metal complexes of technetium in intermediate oxidation states with potentially bidentate oxazoline- and thiazoline-containing ligands were unsuccessful; when pertechnetate was reduced in the presence of excess ligand, TcO2 . xH(2)O was produced. Instead, by reaction with preformed M . O cores, a series of oxotechnetium(V) and oxorhenium(V) complexes of the formula MOXL(2) (M = Re}, keywords = {COORDINATION CHEMISTRY, RADIOPHARMACEUTICALS, RAY CRYSTAL-STRUCTURE, SIDEROPHORE, TC-99M}, isbn = {0020-1669}, url = {://A1996TR24000018}, author = {Shuter, E. and Hoveyda, H. R. and Karunaratne, V. and Rettig, S. J. and Orvig, Chris} } @article {3021, title = {CHARACTERIZATION OF TRIS(N-SUBSTITUTED-2-METHYL-3-HYDROXY-4-PYRIDINONATO)TECHNETIUM(IV) CATIONS}, journal = {Inorganic Chemistry}, volume = {33}, number = {24}, year = {1994}, note = {ISI Document Delivery No.: PU080Times Cited: 14Cited Reference Count: 20}, month = {Nov}, pages = {5607-5609}, type = {Note}, keywords = {3-HYDROXY-4-PYRIDINONES, AGENTS, aluminum, CHEMISTRY, COMPLEXES, gallium, INVIVO, RADIOPHARMACEUTICALS, TC-99M, technetium}, isbn = {0020-1669}, url = {://A1994PU08000042}, author = {Edwards, D. S. and Liu, S. and Poirier, M. J. and Zhang, Z. H. and Webb, G. A. and Orvig, Chris} }